Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis

Clinical trial NCT02275299 · UNKNOWN

Trial details

NCT number: NCT02275299
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2013-09-01
Primary completion: 2016-02-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.